Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, November 09, 2018
Be The Match BioTherapies announced the launch of its Quality System Audit Program (QSAP).
read more
Thursday, February 21, 2019
IQVIA has announced the appointment of Carol J. Burt to its board of directors, effective immediately.
read more
BioIVT announced the opening of its new blood donor center on the Tufts University campus in Medford, MA to support academic and pharmaceutical researchers involved in COVID-19, cell and gene therapy research.
read more
Wednesday, February 10, 2021
FairJourney Biologics and IONTAS have announced the launch of a new protein sciences division, Flow Eighteen38.
read more
Thursday, October 14, 2021
Charles River Laboratories International announced that it has divested its Research Models and Services operations in Japan (RMS Japan) and its gene therapy CDMO site in Sweden (CDMO Sweden) in two separate transactions.
read more
Wednesday, November 18, 2020
Stelis BioSource has started the next phase of its continued investment program.
read more
Wednesday, February 17, 2021
Samsung Biologics announced IND clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy.
read more
Wednesday, August 07, 2024
NovAliX has formed a strategic partnership with Bruker under which Bruker has taken a minority ownership stake in NovAliX. The strategic investment underscores the increasingly vital role being played by CROs in global drug discovery and research.
read more
Alcami announced its collaboration with MDGH, a not-for-profit Australian biopharmaceutical company dedicated to the development of affordable medicines and vaccines for neglected diseases prevalent in low and middle-income countries.
read more
Grand River Aseptic Manufacturing (GRAM) has implemented its fully-automated serialization and aggregation processes for commercial injectable drug products.
read more
Monday, November 04, 2013
Almac’s Clinical Services Business Unit is delighted to announce that Richard Segiel, Jr. has joined the company as Vice President of Business Development for the United States. He brings with him 23 successful years of experience in the contract ...
read more
Friday, December 20, 2013
Following a successful inspection by the German health authorities in July 2013 ChemCon received the approval required to manufacture semi-solid pharmaceuticals (gels and creams for topical therapy) for human use. This was an important step for the ...
read more
Cardinal Health will spend about $1.12 billion to buy pharmaceutical distributor The Harvard Drug Group in a deal that aims to build its generic and over-the-counter drug businesses.
read more
Dr. Reddy’s Laboratories and CHD Bioscience announced a global licensing agreement for the clinical development and commercialization of Dr. Reddy’s Phase III clinical trial candidate, DFA-02.
read more
SGS announced that its Fairfield laboratory has earned its ISO/IEC 17025:2017 certification.
The globally recognized accreditation, together with Fairfield’s extensive experience as a GMP FDA approved laboratory, allows SGS to clearly demonstrate ...
read more